Welcome to Visited Lingnan Modern Clinics In Surgery, Today is

Lingnan Modern Clinics In Surgery ›› 2023, Vol. 23 ›› Issue (03): 263-268.DOI: 10.3969/j.issn.1009-976X.2023.03.010

• Review • Previous Articles     Next Articles

Research progress of sphingomyelinase in gastrointestinal cancers

WANG Rong-yue1,2, SU Yan-ze2, CHEN Er-bao2, LIU Ji-kui2   

  1. 1. Department of Clinical Medicine, Zunyi Medical University, Zunyi, Guizhou 563000, China;
    2. Department of Hepatobiliary and Pancreatic Surgery, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, China
  • Contact: CHEN Er-bao, pandachen1990@163.com; LIU Ji-kui, liu8929@126.com

鞘磷脂酶在消化道恶性肿瘤中的研究进展

王荣悦1,2, 苏延泽2, 陈二宝2,*, 刘吉奎2,*   

  1. 1.遵义医科大学,贵州遵义 563000;
    2.北京大学深圳医院肝胆胰外科,广东深圳 518036
  • 通讯作者: *陈二宝,Email:pandachen1990@163.com;刘吉奎Email:liu8929@126.com

Abstract: SMPD protein family is a kind of hydrolase that plays a major role in sphingomyelin metabolism. At present, relative researches have found that the members of SMPD are abnormally expressed in different types of tumors, and play a key role in the occurrence, development and drug resistance of cancer. Thus, SMPD family is expected to be a potential predictor for tumor diagnosis, prognosis and treatment. Therefore, this review summarizes the structure and function of SMPD gene and protein, and elucidates the research finding of SMPD in gastrointestinal cancers, which provides new ways and strategies into precision medicine and prognosis evaluation.

Key words: sphingomyelinase, gastrointestinal cancers, targeted therapy

摘要: 鞘磷脂酶(SMPD)是一种可以将鞘磷脂水解为神经酰胺和磷酸胆碱的水解酶,在鞘磷脂代谢中起主要作用。相关研究显示,SMPD家族在多种类型肿瘤中异常表达,并且在肿瘤发生、发展、耐药等方面发挥重要调控作用。因此SMPD有望成为肿瘤诊断和预后预测的标志物及治疗靶点,具有重要的临床转化价值。本文集中阐述了SMPD全家族分子的结构和功能特点,并综述SMPD在消化道恶性肿瘤中的作用及其机制研究进展,从而为消化道恶性肿瘤的靶向治疗及患者预后评估提供新的研究思路和策略。

关键词: 消化道恶性肿瘤, 鞘磷脂酶, 靶向治疗

CLC Number: